Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin-Ichi Ueno

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|February 15, 2024
Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathologyYuta Ishiguro, Taiji Tsunemi, Tomoyo Shimada, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 29, 2014
Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indicesKiyohisa Kamimura, Yoshihiko Fukukura, Tomohide Yoneyama, et al.
Plos One|September 28, 2019
Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsyAkio Mori, Kei-Ichi Ishikawa, Shinji Saiki, et al.
Scientific Reports|September 21, 2021
Non-invasive diagnostic tool for Parkinson's disease by sebum RNA profile with machine learningYuya Uehara, Shin-Ichi Ueno, Haruka Amano-Takeshige, et al.
Cells|January 2, 2019
Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson's DiseaseShin-Ichi Ueno, Shinji Saiki, Motoki Fujimaki, et al.
Journal of Neuroinflammation|February 11, 2025
α-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson's diseaseEmi Furusawa-Nishii, Bataa Solongo, Kou Rai, et al.
Annals of Neurology|September 21, 2022
Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PDKengo Miyamoto, Shinji Saiki, Hirotaka Matsumoto, et al.
Annals of Clinical and Translational Neurology|March 27, 2019
Metabolomics-based identification of metabolic alterations in PARK2Ayami Okuzumi, Taku Hatano, Shin-Ichi Ueno, et al.
Journal of the Neurological Sciences|May 24, 2024
Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER studyNoriko Nishikawa, Taku Hatano, Kenya Nishioka, et al.
Plos One|January 23, 2025
Comparison of actionable alterations in cancers with kinase fusion, mutation, and copy number alterationShinsuke Suzuki, Toshiaki Akahane, Akihide Tanimoto, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|February 15, 2024
Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathologyYuta Ishiguro, Taiji Tsunemi, Tomoyo Shimada, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 29, 2014
Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indicesKiyohisa Kamimura, Yoshihiko Fukukura, Tomohide Yoneyama, et al.
Plos One|September 28, 2019
Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsyAkio Mori, Kei-Ichi Ishikawa, Shinji Saiki, et al.
Scientific Reports|September 21, 2021
Non-invasive diagnostic tool for Parkinson's disease by sebum RNA profile with machine learningYuya Uehara, Shin-Ichi Ueno, Haruka Amano-Takeshige, et al.
Cells|January 2, 2019
Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson's DiseaseShin-Ichi Ueno, Shinji Saiki, Motoki Fujimaki, et al.
Journal of Neuroinflammation|February 11, 2025
α-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson's diseaseEmi Furusawa-Nishii, Bataa Solongo, Kou Rai, et al.
Annals of Neurology|September 21, 2022
Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PDKengo Miyamoto, Shinji Saiki, Hirotaka Matsumoto, et al.
Annals of Clinical and Translational Neurology|March 27, 2019
Metabolomics-based identification of metabolic alterations in PARK2Ayami Okuzumi, Taku Hatano, Shin-Ichi Ueno, et al.
Journal of the Neurological Sciences|May 24, 2024
Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER studyNoriko Nishikawa, Taku Hatano, Kenya Nishioka, et al.
Plos One|January 23, 2025
Comparison of actionable alterations in cancers with kinase fusion, mutation, and copy number alterationShinsuke Suzuki, Toshiaki Akahane, Akihide Tanimoto, et al.
Pageof 4